| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/20/1999 | EP0891773A1 Use of gamma-linolenic acid for preventing oxydative stress |
| 01/20/1999 | EP0891772A2 Therapeutic agent for rheumatic disease comprising nonsteroidal anti-inflamatory drug and phenylpropionic acid derivative |
| 01/20/1999 | EP0891771A1 Compositions comprising lysine and ascorbate compounds for the treatment and prevention of cardiovascular diseases |
| 01/20/1999 | EP0891719A1 Nutritional composition containing methionine |
| 01/20/1999 | EP0891429A2 Recombinant aav vector-based transduction system and use of same |
| 01/20/1999 | EP0891428A1 Phosphatidylinositol 3-kinase p110 delta catalytic subunit |
| 01/20/1999 | EP0891425A2 Methods and compositions for regulating t cell subsets by modulating transcription factor activity |
| 01/20/1999 | EP0891424A1 Human cachexia associated protein |
| 01/20/1999 | EP0891422A1 Complex superoxide dismutase product |
| 01/20/1999 | EP0891378A1 Use of a pharmaceutical composition comprising an appetite-suppressing peptide |
| 01/20/1999 | EP0891377A1 Inhibitor and stimulator of stem cell proliferation and uses thereof |
| 01/20/1999 | EP0891376A1 Antifungal peptides from scleroderma texense |
| 01/20/1999 | EP0891375A1 Peptidyl compounds having mmp and tnf- liberation inhibitory activity |
| 01/20/1999 | EP0891374A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 01/20/1999 | EP0891372A1 Growth factor htter36 |
| 01/20/1999 | EP0891365A1 Benzoxazines for enhancing synaptic response |
| 01/20/1999 | EP0891364A1 Calixpyrroles, calixpyridinopyrroles and calixpyridines |
| 01/20/1999 | EP0891363A1 Heterocyclic compounds and their preparation and use |
| 01/20/1999 | EP0891362A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 01/20/1999 | EP0891361A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891360A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891359A1 Novel oxazolidine derivatives, process for their production and medicaments containing them |
| 01/20/1999 | EP0891358A1 Oxazolidin-2-one derivatives, preparation method therefor and therapeutical use thereof |
| 01/20/1999 | EP0891357A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891356A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891355A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891354A1 N-aminoalkyldibenzofurancarboxamides as dopamine receptor subtype specific ligands |
| 01/20/1999 | EP0891353A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891352A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891351A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891350A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891349A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891347A1 Triterpene derivatives with immunosuppressant activity |
| 01/20/1999 | EP0891346A1 Dihydrobenzofuran compounds useful as anti-inflammatory agents |
| 01/20/1999 | EP0891345A1 Novel furan diarylmethylidene derivatives, method for their preparation and therapeutical uses thereof |
| 01/20/1999 | EP0891344A1 Alpha 1-adrenergic receptor antagonists |
| 01/20/1999 | EP0891343A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891339A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891338A1 Bioconjugates of manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
| 01/20/1999 | EP0891337A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891335A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891334A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891333A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891332A1 6-phenylpyridyl-2-amine derivatives |
| 01/20/1999 | EP0891331A1 N-(2 oxoacetyl or sulphonyl)-pyrrolidine/piperidine-2-carboxylic acid derivatives with improved multi-drug resistance activity |
| 01/20/1999 | EP0891329A1 Peptidyl compounds having mmp and tnf inhibitory activity |
| 01/20/1999 | EP0891328A1 Peptidyl compounds having mmp and tnf inhibitory activity |
| 01/20/1999 | EP0891326A1 Novel vitamin d analogues |
| 01/20/1999 | EP0891325A1 Para-substituted phenylpropanoic acid derivatives as integrin antagonists |
| 01/20/1999 | EP0891322A1 Dimethyl-substituted cyclohexane diene derivatives |
| 01/20/1999 | EP0891319A1 Novel benzaldehyde derivatives from hericeum erinaceus |
| 01/20/1999 | EP0891189A1 Medicament for optimising mucosal viscosity and stimulating intestinal function |
| 01/20/1999 | EP0891188A1 Steroids as neurochemical initiators of change in human blood levels of lh or fsh |
| 01/20/1999 | EP0891187A1 Use of derivatives of tetrahydro-beta-carbolines as antimetastatic agents |
| 01/20/1999 | EP0891186A1 Nasal administration of agents for treatment of delayed onset emesis |
| 01/20/1999 | EP0891185A2 Use of 2-(3,4-dimethoxycinnamoyl)aminobenzoic acid for the manufacture of a medicament for the treatment or prevention of restenosis |
| 01/20/1999 | EP0891184A1 Method for solubilising hydrophylic materials (e.g. proteins) in a hydrophobic solvent |
| 01/20/1999 | EP0891133A1 Corneal storage fluid comprised of hyaluronic acid |
| 01/20/1999 | EP0871440A4 Treatment of negative and cognitive symptoms of schizophrenia with glycine uptake antagonists |
| 01/20/1999 | EP0855913A4 Iron dextran formulations |
| 01/20/1999 | EP0790986B1 Aniline derivatives |
| 01/20/1999 | EP0778775B1 Cosolvent parenteral formulation of tirilazad |
| 01/20/1999 | EP0774958B1 Vesicle formulation comprising non-ionic surfactant |
| 01/20/1999 | EP0767657A4 Novel method of preparation of known and novel 2'-modified nucleosides by intramolecular nucleophilic displacement |
| 01/20/1999 | EP0764149B1 Novel farnesyl transferase inhibitors, their preparation and pharmaceutical compositions containing same |
| 01/20/1999 | EP0759986B1 Diagnostics for cancers expressing tyrosine phosphorylated crkl protein |
| 01/20/1999 | EP0725623B1 Cosmetic composition comprising a hydrocalchone and retinol or a derivative thereof |
| 01/20/1999 | EP0719259B1 Substituted pyridines and pyrimidines, process for producing them and their use as pesticides and fungicides |
| 01/20/1999 | EP0707579B1 Piperidinyl substituted methanoanthracenes as d1/d2-antagonists and 5ht2-serotanin-antagonists |
| 01/20/1999 | EP0693053B1 Urea and amide derivatives and their use in the control of cell membrane potassium channels |
| 01/20/1999 | EP0689428B1 Enhanced circulation effector composition and method |
| 01/20/1999 | EP0688208B1 Sugar- and sodium-free effervescent tablets and granules and process for preparing same |
| 01/20/1999 | EP0675714B1 COMBINATION OF A CHOLESTEROL BIOSYNTHESIS INHIBITOR AND A $g(b)-LACTAM CHOLESTEROL ABSORPTION INHIBITOR |
| 01/20/1999 | EP0674624B1 Pyrazoles having crf antagonist activity |
| 01/20/1999 | EP0655911B1 Ophthalmological preparation |
| 01/20/1999 | EP0641327B1 Novel alpha-mannosidase inhibitors |
| 01/20/1999 | EP0637310B1 Water-soluble retinoids |
| 01/20/1999 | EP0630245B1 Protein kinase c inhibitor |
| 01/20/1999 | EP0630242B1 Further indole derivatives with antiviral activity |
| 01/20/1999 | EP0592433B1 Sertindole prodrugs |
| 01/20/1999 | EP0573628B1 New a83543 compounds and process for production thereof |
| 01/20/1999 | CN1205738A OB protein derivatives having prolonged half-life |
| 01/20/1999 | CN1205707A Sugar-substituted 2-azetidinones useful as hypocholesterolemic gents |
| 01/20/1999 | CN1205706A Novel cephalosporin derivatives and processes for prepn. thereof |
| 01/20/1999 | CN1205704A 2,7-substituted octahydro-pyrrolo (1,2-A) pyrazine derivatives |
| 01/20/1999 | CN1205703A Polymorphic foams of growth hormone secretagogue |
| 01/20/1999 | CN1205702A Pyrido (2,3-b) pyrazine derivatives |
| 01/20/1999 | CN1205701A Trans apovincaminic acid ester derivatives as drugs |
| 01/20/1999 | CN1205700A Indolenlkyl derivatives of benzodioxanmethylamine as 5-HT1A receptor ligands |
| 01/20/1999 | CN1205699A 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives |
| 01/20/1999 | CN1205698A Heterocyclyl-condensed benzoylguanidines, their prodn. and use as inhibitors of cellular Na+/H+-antiporter |
| 01/20/1999 | CN1205697A Novel taxoids, prepn. thereof and pharmaceutical compsns. containing same |
| 01/20/1999 | CN1205695A N-substituted dioxothiazolidylbenzamide derivatives and process for producing same |
| 01/20/1999 | CN1205694A Quinazoline derivatives |
| 01/20/1999 | CN1205693A Quinoline and quinazoline compounds useful in therapy |
| 01/20/1999 | CN1205689A Novel 2,3,5-trimethyl-4-hydroxy anilide derivatives, prepn. thereof and therapeutical use thereof |
| 01/20/1999 | CN1205687A Tyrosin-derivate as alpha-V-integrin inhibitors |
| 01/20/1999 | CN1205641A Administration media for analygesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compsns. containing such media and drugs |
| 01/20/1999 | CN1205640A Method of treating disorders characterized by overexpression of cytidine deaminase or deoxycytidine deaminase |
| 01/20/1999 | CN1205639A Contraceptive process and kit for female mammals, comprising combination of gestagen and oestrogen |